-
Electronic (PDF)
-
Site License
-
Enterprisewide
United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017
Global Markets Direct, January 2012, Pages: 144
United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017
Summary
”United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the United Arab Emirates In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.
Scope
- Market size and company share data for In Vitro Diagnostics market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
- Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the United Arab Emirates In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Beckman Coulter, Inc., Abbott Laboratories, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the United Arab Emirates In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 In Vitro Diagnostics In United Arab Emirates
3.1 In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Actual, 2003-2017
3.2 In Vitro Diagnostics, United Arab Emirates, Company share (2009-2010)
4 Clinical Chemistry In United Arab Emirates
4.1 Clinical Chemistry Overall Revenue (2003-2017)
4.1.1 Clinical Chemisty Analyzers Revenue (2003-2017)
4.1.2 Urine Analysis Revenue (2003-2017)
4.2 Clinical Chemistry Distribution Share (2009-2010)
4.3 Clinical Chemistry, United Arab Emirates, Company share (2009-2010)
5 Genetic Testing In United Arab Emirates
5.1 Genetic Testing Overall Revenue (2003-2017)
5.2 Genetic Testing Distribution Share (2009-2010)
5.3 Genetic Testing, United Arab Emirates, Company share (2009-2010)
6 Haematology In United Arab Emirates
6.1 Haematology Overall Revenue (2003-2017)
6.1.1 Haematology Reagents Revenue (2003-2017)
6.1.2 Immunohaematology Revenue (2003-2017)
6.1.3 Haemostasis Revenue (2003-2017)
6.1.4 Haematology Rapid Tests Revenue (2003-2017)
6.1.5 Haematology Cell Counters Revenue (2003-2017)
6.2 Haematology Distribution Share (2009-2010)
6.3 Haematology, United Arab Emirates, Company share (2009-2010)
7 Histology And Cytology In United Arab Emirates
7.1 Histology And Cytology Overall Revenue (2003-2017)
7.2 Histology And Cytology Distribution Share (2009-2010)
7.3 Histology And Cytology, United Arab Emirates, Company share (2009-2010)
8 Immuno Chemistry In United Arab Emirates
8.1 Immuno Chemistry Overall Revenue (2003-2017)
8.1.1 Disease Specific Immunochemistry Revenue (2003-2017)
8.1.2 Drugs of Abuse / Toxicology Revenue (2003-2017)
8.1.3 Endocrinology Tests Revenue (2003-2017)
8.1.4 Therapeutic Drug Monitoring Revenue (2003-2017)
8.1.5 Immunochemistry Analyzers Revenue (2003-2017)
8.2 Immuno Chemistry Distribution Share (2009-2010)
8.3 Immuno Chemistry, United Arab Emirates, Company share (2009-2010)
9 Infectious Immunology In United Arab Emirates
9.1 Infectious Immunology Overall Revenue (2003-2017)
9.2 Infectious Immunology Distribution Share (2009-2010)
9.3 Infectious Immunology, United Arab Emirates, Company share (2009-2010)
10 Microbiology Culture In United Arab Emirates
10.1 Microbiology Culture Overall Revenue (2003-2017)
10.1.1 Microbiology Analyzers Revenue (2003-2017)
10.2 Microbiology Culture Distribution Share (2009-2010)
10.3 Microbiology Culture, United Arab Emirates, Company share (2009-2010)
11 Overview of Key Companies in United Arab Emirates In Vitro Diagnostics Market
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 Company Overview
11.2 Siemens Healthcare
11.2.1 Company Overview
11.3 Beckman Coulter, Inc.
11.3.1 Company Overview
11.4 Abbott Laboratories
11.4.1 Company Overview
11.5 Ortho-Clinical Diagnostics Inc.
11.5.1 Company Overview
11.6 bioMerieux S.A.
11.6.1 Company Overview
11.7 The Elitech Group
11.7.1 Company Overview
11.8 Alere Inc.
11.8.1 Company Overview
11.9 Becton, Dickinson and Company
11.9.1 Company Overview
11.10 DiaSorin S.p.A
11.10.1 Company Overview
11.11 Bio-Rad Laboratories, Inc.
11.11.1 Company Overview
11.12 Mindray Medical International Limited
11.12.1 Company Overview
11.13 Phadia AB
11.13.1 Company Overview
11.14 Thermo Fisher Scientific Inc.
11.14.1 Company Overview
11.15 HORIBA, Ltd.
11.15.1 Company Overview
11.16 Sysmex Corporation
11.16.1 Company Overview
11.17 Grifols, S.A.
11.17.1 Company Overview
11.18 Qiagen N.V.
11.18.1 Company Overview
11.19 Gen-Probe Incorporated
11.19.1 Company Overview
11.20 DIAGNOSTICA STAGO, Inc.
11.20.1 Company Overview
11.21 Immucor, Inc.
11.21.1 Company Overview
11.22 PerkinElmer, Inc.
11.22.1 Company Overview
11.23 Life Technologies Corporation
11.23.1 Company Overview
11.24 Hologic, Inc.
11.24.1 Company Overview
11.25 Chembio Diagnostic, Inc.
11.25.1 Company Overview
12 APPENDIX
12.1 Global Markets Direct Research Methodology
12.2 Definitions of Markets Covered in the Report
12.2.1 In Vitro Diagnostics
12.3 Secondary Research
12.4 Primary Research
12.5 Models
12.6 Forecasts
12.7 Expert Panel Validation
12.8 Currency Conversion
12.9 Contact Us
12.10 Disclaimer
1.1 List of Tables
Table 1: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Actual, 2003-2017
Table 2: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Table 3: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Table 4: In Vitro Diagnostics, United Arab Emirates, Company share by Revenue ($m), USD Actual, 2009-2010
Table 5: Clinical Chemistry, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 6: Clinical Chemistry, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 7: Clinical Chemisty Analyzers, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 8: Clinical Chemisty Analyzers, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 9: Urine Analysis, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 10: Urine Analysis, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 11: Clinical Chemistry, United Arab Emirates, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 12: Clinical Chemistry, United Arab Emirates, Company share by Revenue ($m), USD Actual 2009-2010
Table 13: Genetic Testing, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 14: Genetic Testing, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 15: Genetic Testing, United Arab Emirates, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 16: Genetic Testing, United Arab Emirates, Company share by Revenue ($m), USD Actual 2009-2010
Table 17: Haematology, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 18: Haematology, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 19: Haematology Reagents, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 20: Haematology Reagents, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 21: Immunohaematology, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 22: Immunohaematology, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 23: Haemostasis, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 24: Haemostasis, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 25: Haematology Rapid Tests, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 26: Haematology Rapid Tests, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 27: Haematology Cell Counters, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 28: Haematology Cell Counters, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 29: Haematology, United Arab Emirates, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 30: Haematology, United Arab Emirates, Company share by Revenue ($m), USD Actual 2009-2010
Table 31: Histology And Cytology, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 32: Histology And Cytology, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 33: Histology And Cytology, United Arab Emirates, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 34: Histology And Cytology, United Arab Emirates, Company share by Revenue ($m), USD Actual 2009-2010
Table 35: Immuno Chemistry, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 36: Immuno Chemistry, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 37: Disease Specific Immunochemistry, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 38: Disease Specific Immunochemistry, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 39: Drugs of Abuse / Toxicology, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 40: Drugs of Abuse / Toxicology, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 41: Endocrinology Tests, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 42: Endocrinology Tests, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 43: Therapeutic Drug Monitoring, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 44: Therapeutic Drug Monitoring, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 45: Immunochemistry Analyzers, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 46: Immunochemistry Analyzers, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 47: Immuno Chemistry, United Arab Emirates, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 48: Immuno Chemistry, United Arab Emirates, Company share by Revenue ($m), USD Actual 2009-2010
Table 49: Infectious Immunology, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 50: Infectious Immunology, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 51: Infectious Immunology, United Arab Emirates, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 52: Infectious Immunology, United Arab Emirates, Company share by Revenue ($m), USD Actual 2009-2010
Table 53: Microbiology Culture, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 54: Microbiology Culture, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 55: Microbiology Analyzers, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 56: Microbiology Analyzers, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 57: Microbiology Culture, United Arab Emirates, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 58: Microbiology Culture, United Arab Emirates, Company share by Revenue ($m), USD Actual 2009-2010
Table 59: USD to Local Currency, United Arab Emirates, Average Actual Rate 2003-2010
1.2 List of Figures
Figure 1: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Actual, 2003-2017
Figure 2: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Figure 3: In Vitro Diagnostics, United Arab Emirates, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 4: In Vitro Diagnostics, United Arab Emirates, Company share (%), 2010
Figure 5: Clinical Chemistry, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 6: Clinical Chemistry, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 7: Clinical Chemisty Analyzers, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 8: Clinical Chemisty Analyzers, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 9: Urine Analysis, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 10: Urine Analysis, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 11: Clinical Chemistry, United Arab Emirates, Company share (%), 2010
Figure 12: Genetic Testing, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 13: Genetic Testing, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 14: Genetic Testing, United Arab Emirates, Company share (%), 2010
Figure 15: Haematology, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 16: Haematology, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 17: Haematology Reagents, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 18: Haematology Reagents, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 19: Immunohaematology, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 20: Immunohaematology, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 21: Haemostasis, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 22: Haemostasis, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 23: Haematology Rapid Tests, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 24: Haematology Rapid Tests, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 25: Haematology Cell Counters, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 26: Haematology Cell Counters, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 27: Haematology, United Arab Emirates, Company share (%), 2010
Figure 28: Histology And Cytology, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 29: Histology And Cytology, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 30: Histology And Cytology, United Arab Emirates, Company share (%), 2010
Figure 31: Immuno Chemistry, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 32: Immuno Chemistry, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 33: Disease Specific Immunochemistry, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 34: Disease Specific Immunochemistry, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 35: Drugs of Abuse / Toxicology, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 36: Drugs of Abuse / Toxicology, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 37: Endocrinology Tests, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 38: Endocrinology Tests, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 39: Therapeutic Drug Monitoring, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 40: Therapeutic Drug Monitoring, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 41: Immunochemistry Analyzers, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 42: Immunochemistry Analyzers, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 43: Immuno Chemistry, United Arab Emirates, Company share (%), 2010
Figure 44: Infectious Immunology, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 45: Infectious Immunology, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 46: Infectious Immunology, United Arab Emirates, Company share (%), 2010
Figure 47: Microbiology Culture, United Arab Emirates, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 48: Microbiology Culture, United Arab Emirates, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 49: Microbiology Analyzers, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 50: Microbiology Analyzers, United Arab Emirates, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 51: Microbiology Culture, United Arab Emirates, Company share (%), 2010
Figure 52: Global Markets Direct Methodology
F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Beckman Coulter, Inc.
Abbott Laboratories
Ortho-Clinical Diagnostics Inc.
bioMerieux S.A.
The Elitech Group
Alere Inc.
Becton, Dickinson and Company
DiaSorin S.p.A
Bio-Rad Laboratories, Inc.
Mindray Medical International Limited
Phadia AB
Thermo Fisher Scientific Inc.
HORIBA, Ltd.
Sysmex Corporation
Grifols, S.A.
Qiagen N.V.
Gen-Probe Incorporated
DIAGNOSTICA STAGO, Inc.
Immucor, Inc.
PerkinElmer, Inc.
Life Technologies Corporation
Hologic, Inc.
Chembio Diagnostic, Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
